Chemotherapy Nerve Damage: New Drug Trial Shows Promise
“`html
Chemotherapy-Induced Neuropathy Linked to Immune Cell Stress Response
Table of Contents
New research from Weill Cornell Medicine and Wake forest University School of Medicine reveals a connection between chemotherapy, immune cell stress, and the progress of chemotherapy-induced peripheral neuropathy (CIPN), a debilitating side effect affecting up to half of cancer patients.
Published November 23, 2023, this study offers potential avenues for prevention and early identification of at-risk patients.
Understanding Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Chemotherapy-induced peripheral neuropathy (CIPN) is a common and often debilitating side effect of cancer treatment.It manifests as tingling, numbness, and pain, typically in the hands and feet. According to the National Cancer Institute, CIPN impacts up to half of all individuals receiving chemotherapy. The severity of CIPN varies widely, but for many patients, it’s severe enough to necessitate a reduction in chemotherapy dosage or even premature termination of treatment, possibly compromising cancer treatment efficacy.
Currently, effective treatments for CIPN are limited, highlighting the urgent need for a deeper understanding of its underlying mechanisms. This new research offers a meaningful step forward in that direction.
the Immune Cell Connection: A Novel Discovery
The study, published on October 29, 2023, in Science Translational Medicine, challenges the conventional understanding of CIPN as solely a nerve-related issue. Researchers at Weill Cornell Medicine and Wake Forest University School of Medicine discovered that chemotherapy activates a stress-sensing system within immune cells. The research demonstrates that this activation triggers inflammation and nerve injury, contributing to the development of CIPN.
“We uncovered a molecular mechanism that maps specifically to immune cells, not neurons,” explained Dr. Juan Cubillos-Ruiz, co-senior author and the William J. Ledger, M.D. Distinguished Associate Professor of Infection and Immunology in Obstetrics and Gynecology at Weill Cornell Medicine. “This provides strong evidence that chemotherapy-induced neuropathy is not just a nerve issue but an immune-mediated inflammatory process driven by cellular stress responses.”
the research was co-led by Dr. E. Alfonso Romero-Sandoval, professor of anesthesiology at Wake Forest University School of medicine.
How the IRE1α-XBP1 Pathway Fuels Pain
The researchers focused on a cellular stress pathway known as IRE1α-XBP1. Previous work by Dr. Cubillos-Ruiz and his team had established that this pathway functions as a molecular “alarm system” within immune cells,activating when they encounter stress. The current study reveals that chemotherapy triggers this alarm system, leading to the release of inflammatory molecules that damage nerve cells.